humanitarian

Human medicines European public assessment report (EPAR): Apretude, cabotegravir, Date of authorisation: 15/09/2023, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Oncaspar, pegaspargase, Date of authorisation: 14/01/2016, Revision: 21, Status: Authorised

Reported by EMA What Is New
Read the complete report at EMA What Is New ↗
Verification notice

IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.

INCIDENT FUSION

12 reports · 2 sources

EMA What Is NewHuman medicines European public assessment report (EPAR): Apretude, cabotegravir, Date of authorisation: 15/09/2023, Revision: 2, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Apretude, cabotegravir, Date of authorisation: 15/09/2023, Revision: 2, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Rytelo, imetelstat, Date of authorisation: 07/03/2025, Revision: 2, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Rytelo, imetelstat, Date of authorisation: 07/03/2025, Revision: 2, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Nulojix, belatacept, Date of authorisation: 17/06/2011, Revision: 23, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Nulojix, belatacept, Date of authorisation: 17/06/2011, Revision: 23, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Yesintek, ustekinumab, Date of authorisation: 14/02/2025, Revision: 5, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Yesintek, ustekinumab, Date of authorisation: 14/02/2025, Revision: 5, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Usrenty, ustekinumab, Date of authorisation: 17/09/2025, Revision: 3, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Usrenty, ustekinumab, Date of authorisation: 17/09/2025, Revision: 3, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Abiraterone Mylan, abiraterone acetate, Date of authorisation: 20/08/2021, Revision: 8, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Abiraterone Mylan, abiraterone acetate, Date of authorisation: 20/08/2021, Revision: 8, Status: Authorised
INCIDENT EVOLUTION

4 recorded states

Signal first indexedP2 · 99% quality · 2 sources

Source details updatedP2 · 99% quality · 2 sources

Headline updatedP2 · 99% quality · 2 sources

Source details updatedP2 · 99% quality · 2 sources

Explore this day in the archive →
QUALITY CONTROL

Report this signal

Reports are anonymous and retained privately for editorial review.